3-acetyl-6-chloro-4-(3,4-difluorophenyl)quinolin-2(1H)-one, 95.0%, 500mg

Phenol, m-(methylthio)-, 98%, 50g

2,2-Dimethyl-1,3-dioxolane-4-carboxylic acid, 95.0%, 1g

METHYL 6-BROMO-1-(SEC-BUTYL)-3-FORMYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 1g

2-Chloropyridine-5-carbothioic acid amide, 95.0%, 5g

3-(3,5-Dimethylisoxazol-4-yl)propan-1-amine hydrochloride, 97%, 5g

5-Chlorobenzo[d]oxazole-2-thiol, 95.0%, 10g

(4S,5S)-2-(2-(Diphenylphosphanyl)phenyl)-4,5-diphenyl-4,5-dihydrooxazole, 98%, 1g

1-Bromo-5-(1,3-dioxolan-2-yl)thiophene, 97.0%, 1g

Trial kit Spectra/Por® 1-3 Spectra/Por® 2 - MWCO 12,000–14,000, 45 mm, 1 Piece(s)

N-(7-BROMOISOQUINOLIN-3-YL)CYCLOPROPANECARBOXAMIDE, 95.0%, 250mg

BENZAMIDE, 3-(AMINOSULFONYL)-4-CHLORO-N-[(1,5-DIMETHYL-1H-PYRROL-2-YL)METHYL]-, 95.0%, 50mg

(R)-2-Amino-1,1,1-trifluoropropane hydrochloride, 99.0%, 5g